secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenaya Therapeutics, Inc. (TNYA)
CIK:        0001858848
Form:       8-K
Filed at:   2025-05-30T23:59:59+00:00
Accession:  0000950170-25-079773
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Tenaya Therapeutics shareholders elect all three Class I directors and ratify Deloitte as auditor
--------------------------------------------------------------------------------

- David Goeddel, Ph.D. elected with 80,444,762 votes for, 8,262,596 withheld.
- Jeffrey T. Walsh elected with 70,717,277 for, 17,990,081 withheld.
- R. Sanders Williams elected with 70,410,874 for, 18,296,484 withheld.
- Ratification of Deloitte & Touche LLP passed with 120,339,858 for, 416,705 against, 192,213 abstain.
- Broker non-votes of 32,241,417 on each director nominee; none on auditor ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858848/000095017025079773/0000950170-25-079773-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858848/000095017025079773/tnya-20250528.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-079773

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer